Dr. Sarah P. Cate

Elisa Port is a Surgical Oncologist and a General Surgeon in New York, New York. Dr. Port is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.

"Andrew Ashikari, MD, FACS, is a nationally acclaimed surgical oncologist with over 25 years of clinical practice in the New York metropolitan region.Dr. Ashikari's state-of-the-art care includes nipple-sparing mastectomy, a procedure he says enhances cosmetic outcome and provides effective medical benefit for women with breast cancer or who want to reduce hereditary risk. His expertise in this surgery is unparalleled-his team has performed some of the highest volumes of nipple sparing mastectomies than any breast center in the world.""I wanted to be a doctor from a young age. Dr. Ashikari is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, Breast Infection, Fibrocystic Breast Disease, Paget Disease of the Breast, and Lymphadenectomy.

Beth Sieling is a General Surgeon and a Surgical Oncologist in Waterbury, Connecticut. Dr. Sieling is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Lymphadenectomy.